Maurício Guidi Saueressig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maurício Guidi Saueressig has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
Redha Souilamas
Pôle Cardio-Thoracique , Hôpital Européen Georges Pompidou (HEGP) , Paris , France
4 shared publications- Diego Corsetti Mondadori
Hosp Clin Porto Alegre HCPA, Serv Cirurgia Torac, Grp Transplante Pulmao, Porto Alegre, RS, Brazil
3 shared publications - Redha Souilamas
Thoracic Surgery and Lung Transplant Department, European Georges Pompidou, Paris, France
3 shared publications Alexandre H Moreschi
Bronchology Unit Hospital de Clínicas de Porto Alegre Porto Alegre, Brazil
2 shared publications- Alexandre Heitor Moreschi
Porto Alegre Hospital de Clinicas, Porto Alegre, Brazil
2 shared publications Amarilio Vieira de Macedo Neto
Universidade Federal do Rio Grande do Sul, BR
2 shared publications
Latest Publications
- Open Access
- 23 September 2022
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 48 (5) , e20220038
Lung cancer surgery in Brazil during the COVID-19 pandemic: How many were left behind?
- 23 September 2022
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 48 (5) , e20220038
Open AccessLung cancer surgery in Brazil during the COVID-19 pandemic: How many were left behind?
- Open Access
- 31 October 2021
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (5) , e20200635
Use of extracorporeal membrane oxygenation in the management of severe tracheobronchial injuries
- 31 October 2021
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (5) , e20200635
Open AccessUse of extracorporeal membrane oxygenation in the management of severe tracheobronchial injuries
- Open Access
- 25 April 2021
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 26 (9) , e1581-e1588
Outcomes and Prognostic Factors of Patients with Metastatic Colorectal Cancer Who Underwent Pulmonary Metastasectomy with Curative Intent: A Brazilian Experience
Background We aimed to identify clinicopathological and molecular features associated with progression‐free survival (PFS) and overall survival (OS) after pulmonary metastasectomy for metastatic colorectal cancer in a retrospective cohort in Brazil. Materials and Methods We did a retrospective review of thoracic surgeries performed in a single large academic hospital in Brazil from January 1985 to September 2019. Demographics, previously described prognostic factors, and clinicopathological and molecular characteristics were abstracted. Univariate Cox regression was performed for each variable, and, when significant, data were dichotomized to provide clinically meaningful thresholds. Results Records from 698 patients were reviewed. Fifty‐eight patients underwent pulmonary metastasectomy with curative intent. Of those, 53.4% had a single metastatic lesion. The median size of the largest lesion was 1.5 cm. Results of RAS, RAF, and mismatch repair testing and of cytokeratin 20 (CK20) and CDX2 testing were available for 13.8% and 58.6% of the sample, respectively. Median PFS was 14 months, median OS was 58 months, and 5‐year survival was 49.8%. Unfavorable prognostic factors for OS included disease‐free interval (DFI) <24 months, synchronous presentation, size of the largest lesion ≥2 cm, and loss of CK20 expression. Presenting with more than one lesion was prognostic for PFS but not for OS. Conclusion In this Brazilian cohort, our findings corroborate existing data supporting DFI, synchronous presentation, and number and size of lesions as prognostic factors. Furthermore, we found that loss of CK20 expression may be associated with more aggressive disease and shorter OS. Additional molecular prognostic factors after pulmonary metastasectomy for colorectal cancer should be further explored. Implications for Practice This study consolidates disease‐free interval, synchronous presentation, and number and size of lesions as clinically relevant data that may help guide therapy for patients with colorectal cancer and lung metastases who are candidates for curative‐intent metastasectomy. Additionally, in this sample, lack of cytokeratin 20 expression in metastases was associated with shorter progression‐free survival and overall survival, suggesting that biomarkers also may have a role in guiding therapy in this setting and that additional biomarkers should be further explored.
- 25 April 2021
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 26 (9) , e1581-e1588
Open AccessOutcomes and Prognostic Factors of Patients with Metastatic Colorectal Cancer Who Underwent Pulmonary Metastasectomy with Curative Intent: A Brazilian Experience
Background We aimed to identify clinicopathological and molecular features associated with progression‐free survival (PFS) and overall survival (OS) after pulmonary metastasectomy for metastatic colorectal cancer in a retrospective cohort in Brazil. Materials and Methods We did a retrospective review of thoracic surgeries performed in a single large academic hospital in Brazil from January 1985 to September 2019. Demographics, previously described prognostic factors, and clinicopathological and molecular characteristics were abstracted. Univariate Cox regression was performed for each variable, and, when significant, data were dichotomized to provide clinically meaningful thresholds. Results Records from 698 patients were reviewed. Fifty‐eight patients underwent pulmonary metastasectomy with curative intent. Of those, 53.4% had a single metastatic lesion. The median size of the largest lesion was 1.5 cm. Results of RAS, RAF, and mismatch repair testing and of cytokeratin 20 (CK20) and CDX2 testing were available for 13.8% and 58.6% of the sample, respectively. Median PFS was 14 months, median OS was 58 months, and 5‐year survival was 49.8%. Unfavorable prognostic factors for OS included disease‐free interval (DFI) <24 months, synchronous presentation, size of the largest lesion ≥2 cm, and loss of CK20 expression. Presenting with more than one lesion was prognostic for PFS but not for OS. Conclusion In this Brazilian cohort, our findings corroborate existing data supporting DFI, synchronous presentation, and number and size of lesions as prognostic factors. Furthermore, we found that loss of CK20 expression may be associated with more aggressive disease and shorter OS. Additional molecular prognostic factors after pulmonary metastasectomy for colorectal cancer should be further explored. Implications for Practice This study consolidates disease‐free interval, synchronous presentation, and number and size of lesions as clinically relevant data that may help guide therapy for patients with colorectal cancer and lung metastases who are candidates for curative‐intent metastasectomy. Additionally, in this sample, lack of cytokeratin 20 expression in metastases was associated with shorter progression‐free survival and overall survival, suggesting that biomarkers also may have a role in guiding therapy in this setting and that additional biomarkers should be further explored.
- Open Access
- 1 January 2021
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (1) , e20200207
Impact of extracorporeal membrane oxygenation in lung transplantation
- 1 January 2021
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (1) , e20200207
Open AccessImpact of extracorporeal membrane oxygenation in lung transplantation
- Open Access
- 10 August 2020
- Published by FapUNIFESP (SciELO) in SciELO Preprints
Estimativa de pacientes hospitalizados por COVID-19 em unidade de terapia intensiva no pico da pandemia em Porto Alegre: Estudo com modelo epidemiológico SEIHDR
Objetivo: Estimar o número máximo de casos prevalentes de COVID-19, internados em unidades de terapia intensiva, e o momento deste pico, em Porto Alegre. Métodos: Empregamos um modelo matemático de equações diferenciais denominado SEIHDR (Suscetível, Exposto, Infectado, Hospitalizado, Morto, Recuperados). Analisamos os casos de hospitalização por COVID-19 em Porto Alegre e RS, desde 9 de março até 25 de julho de 2020 a fim de extrair os parâmetros para construir uma curva epidemiológica do total de casos prevalentes hospitalizados e em unidade de terapia intensiva, assim como estimar a prevalência de pacientes em ventilação mecânica invasiva. Finalmente, ajustamos alguns parâmetros desta curva a partir dos casos reais prevalentes de internados em enfermaria e em unidades de terapia intensiva. Resultados: O modelo matemático corrigido para os dados da pandemia até 25 de julho projetou um pico de 1.354 casos prevalentes hospitalizados: 562 pacientes internados na unidade de terapia intensiva com 378 sob ventilação mecânica no dia 12 de setembro de 2020 (37º semana epidemiológica). Ainda, haveria o pico de 62.514 casos prevalentes de infectados com COVID-19 no início do mesmo mês (36º semana epidemiológica. Calculamos para a pandemia um número de reprodução básico de 1,53 e de reprodução efetiva de 1,29 para 25 de julho de 2020. Conclusão: Como o número atual de leitos de unidade de terapia intensiva seria insuficiente para atender a esta demanda, sugerimos um aumento no número de leitos críticos a fim de evitar o colapso do sistema de saúde em Porto Alegre.
- 10 August 2020
- Published by FapUNIFESP (SciELO) in SciELO Preprints
Open AccessEstimativa de pacientes hospitalizados por COVID-19 em unidade de terapia intensiva no pico da pandemia em Porto Alegre: Estudo com modelo epidemiológico SEIHDR
Objetivo: Estimar o número máximo de casos prevalentes de COVID-19, internados em unidades de terapia intensiva, e o momento deste pico, em Porto Alegre. Métodos: Empregamos um modelo matemático de equações diferenciais denominado SEIHDR (Suscetível, Exposto, Infectado, Hospitalizado, Morto, Recuperados). Analisamos os casos de hospitalização por COVID-19 em Porto Alegre e RS, desde 9 de março até 25 de julho de 2020 a fim de extrair os parâmetros para construir uma curva epidemiológica do total de casos prevalentes hospitalizados e em unidade de terapia intensiva, assim como estimar a prevalência de pacientes em ventilação mecânica invasiva. Finalmente, ajustamos alguns parâmetros desta curva a partir dos casos reais prevalentes de internados em enfermaria e em unidades de terapia intensiva. Resultados: O modelo matemático corrigido para os dados da pandemia até 25 de julho projetou um pico de 1.354 casos prevalentes hospitalizados: 562 pacientes internados na unidade de terapia intensiva com 378 sob ventilação mecânica no dia 12 de setembro de 2020 (37º semana epidemiológica). Ainda, haveria o pico de 62.514 casos prevalentes de infectados com COVID-19 no início do mesmo mês (36º semana epidemiológica. Calculamos para a pandemia um número de reprodução básico de 1,53 e de reprodução efetiva de 1,29 para 25 de julho de 2020. Conclusão: Como o número atual de leitos de unidade de terapia intensiva seria insuficiente para atender a esta demanda, sugerimos um aumento no número de leitos críticos a fim de evitar o colapso do sistema de saúde em Porto Alegre.
- 1 May 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 105 (5) , 1577-1578
Usefulness of Endobronchial Ultrasonography for Ground-Glass Opacity Lesions
- 1 May 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 105 (5) , 1577-1578
Usefulness of Endobronchial Ultrasonography for Ground-Glass Opacity Lesions
- 20 May 2017
- Published by Springer Nature in Biotechnology Letters
- Vol. 39 (8) , 1269-1277
Repeated systemic administration of adipose tissue-derived mesenchymal stem cells prevents tracheal obliteration in a murine model of bronchiolitis obliterans
Objective To investigate the effect of adipose tissue-derived mesenchymal stem cell (ASC) administered either systemically or locally in a murine model of bronchiolitis obliterans. Results When compared to controls, systemic treatment with 106 ASCs on D0 and a second dose on D7 significantly prevented tracheal obliteration 28 days after heterotopic tracheal transplantation (median of 94 vs. 16%; P < 0.01). A single dose tended towards less stenosis than controls, but did not reach statistical significance (28 vs. 94%; P = 0.054). On the contrary, repeated local injection was incapable of preventing tracheal obliteration when compared to a single injection or controls (37 vs. 71 vs. 87%). Two intravenous doses also tended to be better than two local injections (16 vs. 37%; P = 0.058), and were better than a single local dose (16 vs. 71%; P < 0.01). Conclusion A second dose of ASC, given systemically after 7 days, reduces luminal obliteration in a heterotopic tracheal transplantation model in mice, suggesting that ASC can be used to prevent obliterative bronchiolitis after lung transplantation.
- 20 May 2017
- Published by Springer Nature in Biotechnology Letters
- Vol. 39 (8) , 1269-1277
Repeated systemic administration of adipose tissue-derived mesenchymal stem cells prevents tracheal obliteration in a murine model of bronchiolitis obliterans
Objective To investigate the effect of adipose tissue-derived mesenchymal stem cell (ASC) administered either systemically or locally in a murine model of bronchiolitis obliterans. Results When compared to controls, systemic treatment with 106 ASCs on D0 and a second dose on D7 significantly prevented tracheal obliteration 28 days after heterotopic tracheal transplantation (median of 94 vs. 16%; P < 0.01). A single dose tended towards less stenosis than controls, but did not reach statistical significance (28 vs. 94%; P = 0.054). On the contrary, repeated local injection was incapable of preventing tracheal obliteration when compared to a single injection or controls (37 vs. 71 vs. 87%). Two intravenous doses also tended to be better than two local injections (16 vs. 37%; P = 0.058), and were better than a single local dose (16 vs. 71%; P < 0.01). Conclusion A second dose of ASC, given systemically after 7 days, reduces luminal obliteration in a heterotopic tracheal transplantation model in mice, suggesting that ASC can be used to prevent obliterative bronchiolitis after lung transplantation.
- Open Access
- 1 February 2017
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 43 (1) , 76-77
Radial-probe EBUS for the diagnosis of peripheral pulmonary lesions
First, we have found data inconsistencies in Tables 1 and 2 in the aforementioned article. The authors reported, both in the body of the text and in Table 1, that the diagnostic sensitivity of radial-probe EBUS for radial-probe EBUS-visible nodules was 74.1%: 20 surgically confirmed diagnoses among 27 radial-probe EBUS-visible nodules. However, in the second column of Table 2, we found that 21 diagnosed cases of radial-probe EBUS-visible nodules (10 cases of malignant disease and 11 cases of nonmalignant disease) were listed, which differs from the sum of 20 cases recorded in the last row of the same column. Also in Table 2, one case of hamartoma was erroneously included among the malignant nodules.
- 1 February 2017
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 43 (1) , 76-77
Open AccessRadial-probe EBUS for the diagnosis of peripheral pulmonary lesions
First, we have found data inconsistencies in Tables 1 and 2 in the aforementioned article. The authors reported, both in the body of the text and in Table 1, that the diagnostic sensitivity of radial-probe EBUS for radial-probe EBUS-visible nodules was 74.1%: 20 surgically confirmed diagnoses among 27 radial-probe EBUS-visible nodules. However, in the second column of Table 2, we found that 21 diagnosed cases of radial-probe EBUS-visible nodules (10 cases of malignant disease and 11 cases of nonmalignant disease) were listed, which differs from the sum of 20 cases recorded in the last row of the same column. Also in Table 2, one case of hamartoma was erroneously included among the malignant nodules.
- Open Access
- 1 June 2016
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 42 (3) , 215-221
Anatomic pulmonary resection by video-assisted thoracoscopy: the Brazilian experience (VATS Brazil study)
Objective: The objective of this study was to describe the results of anatomic pulmonary resections performed by video-assisted thoracoscopy in Brazil. Methods: Thoracic surgeons (members of the Brazilian Society of Thoracic Surgery) were invited, via e-mail, to participate in the study. Eighteen surgeons participated in the project by providing us with retrospective databases containing information related to anatomic pulmonary resections performed by video-assisted thoracoscopy. Demographic, surgical, and postoperative data were collected with a standardized instrument, after which they were compiled and analyzed. Results: The surgeons provided data related to a collective total of 786 patients (mean number of resections per surgeon, 43.6). However, 137 patients were excluded because some data were missing. Therefore, the study sample comprised 649 patients. The mean age of the patients was 61.7 years. Of the 649 patients, 295 (45.5%) were male. The majority-521 (89.8%)-had undergone surgery for neoplasia, which was most often classified as stage IA. The median duration of pleural drainage was 3 days, and the median hospital stay was 4 days. Of the 649 procedures evaluated, 598 (91.2%) were lobectomies. Conversion to thoracotomy was necessary in 30 cases (4.6%). Postoperative complications occurred in 124 patients (19.1%), the most common complications being pneumonia, prolonged air leaks, and atelectasis. The 30-day mortality rate was 2.0%, advanced age and diabetes being found to be predictors of mortality. Conclusions: Our analysis of this representative sample of patients undergoing pulmonary resection by video-assisted thoracoscopy in Brazil showed that the procedure is practicable and safe, as well as being comparable to those performed in other countries.
- 1 June 2016
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 42 (3) , 215-221
Open AccessAnatomic pulmonary resection by video-assisted thoracoscopy: the Brazilian experience (VATS Brazil study)
Objective: The objective of this study was to describe the results of anatomic pulmonary resections performed by video-assisted thoracoscopy in Brazil. Methods: Thoracic surgeons (members of the Brazilian Society of Thoracic Surgery) were invited, via e-mail, to participate in the study. Eighteen surgeons participated in the project by providing us with retrospective databases containing information related to anatomic pulmonary resections performed by video-assisted thoracoscopy. Demographic, surgical, and postoperative data were collected with a standardized instrument, after which they were compiled and analyzed. Results: The surgeons provided data related to a collective total of 786 patients (mean number of resections per surgeon, 43.6). However, 137 patients were excluded because some data were missing. Therefore, the study sample comprised 649 patients. The mean age of the patients was 61.7 years. Of the 649 patients, 295 (45.5%) were male. The majority-521 (89.8%)-had undergone surgery for neoplasia, which was most often classified as stage IA. The median duration of pleural drainage was 3 days, and the median hospital stay was 4 days. Of the 649 procedures evaluated, 598 (91.2%) were lobectomies. Conversion to thoracotomy was necessary in 30 cases (4.6%). Postoperative complications occurred in 124 patients (19.1%), the most common complications being pneumonia, prolonged air leaks, and atelectasis. The 30-day mortality rate was 2.0%, advanced age and diabetes being found to be predictors of mortality. Conclusions: Our analysis of this representative sample of patients undergoing pulmonary resection by video-assisted thoracoscopy in Brazil showed that the procedure is practicable and safe, as well as being comparable to those performed in other countries.
- Open Access
- 1 June 2015
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 42 (3) , 181-188
Cell therapy in the treatment of bronchiolitis obliterans in a murine model
OBJECTIVE: To evaluate the importance of stem cells derived from adipose tissue in reducing graft inflammation in a murine model of allogeneic heterotopic tracheal transplant.METHODS: We performed a heterotopic tracheal allografting in dorsal subcutaneous pouch and systemically injected 5x105 mesenchymal stem cells derived from adipose tissue. The animals were divided into two groups according to the time of sacrifice: T7 and T21. We also carried out histological analysis and digital morphometry.RESULTS: The T7 animals treated with cell therapy had median obstructed graft area of 0 versus 0.54 of controls (p = 0.635). The treated T21 subjects had median obstructed graft area of 0.25 versus 0 in controls (p = 0.041).CONCLUSION: The systemically injected cell therapy in experimental murine model of bronchiolitis obliterans did not reduce the severity of the allograft inflammation in a statistically significant way in seven days; Conversely, in 21 days, it increased the allograft inflammatory process.
- 1 June 2015
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 42 (3) , 181-188
Open AccessCell therapy in the treatment of bronchiolitis obliterans in a murine model
OBJECTIVE: To evaluate the importance of stem cells derived from adipose tissue in reducing graft inflammation in a murine model of allogeneic heterotopic tracheal transplant.METHODS: We performed a heterotopic tracheal allografting in dorsal subcutaneous pouch and systemically injected 5x105 mesenchymal stem cells derived from adipose tissue. The animals were divided into two groups according to the time of sacrifice: T7 and T21. We also carried out histological analysis and digital morphometry.RESULTS: The T7 animals treated with cell therapy had median obstructed graft area of 0 versus 0.54 of controls (p = 0.635). The treated T21 subjects had median obstructed graft area of 0.25 versus 0 in controls (p = 0.041).CONCLUSION: The systemically injected cell therapy in experimental murine model of bronchiolitis obliterans did not reduce the severity of the allograft inflammation in a statistically significant way in seven days; Conversely, in 21 days, it increased the allograft inflammatory process.